# LiveLeaf, Inc.: Form D filings

LiveLeaf, Inc., a biotechnology company in San Carlos, CA, filed 4 Form D notices with the SEC between 2011 and 2015. The latest, on May 18, 2015, reports $2.3 million sold of a $3.5 million offering to 6 investors.

Find out what LiveLeaf, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20LiveLeaf%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=LiveLeaf%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fliveleaf-inc-1534234)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20LiveLeaf%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=LiveLeaf%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fliveleaf-inc-1534234)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1160 INDUSTRIAL ROAD, #11, San Carlos, CA, 94070
- Phone: (877) 925-2888
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2012
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1534234

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 18, 2015 | New notice | $3,500,000 | $2,250,000 | $1,250,000 | 6 | Jun 13, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1534234/000153423415000001/0001534234-15-000001-index.htm) |
| Sep 6, 2013 | Amendment | $12,000,000 | $3,850,000 | $8,150,000 | 8 | Sep 19, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1534234/000153423413000002/0001534234-13-000002-index.htm) |
| Sep 28, 2012 | New notice | $5,000,000 | $550,000 | $4,450,000 | 1 | Sep 19, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1534234/000153423412000002/0001534234-12-000002-index.htm) |
| Nov 10, 2011 | New notice | $3,806,742 | $2,597,537 | $1,209,205 | 17 | Oct 28, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1534234/000153423411000001/0001534234-11-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Michael Ullman | Director |  |
| Gin Wu | Executive Officer, Director |  |
| David Chein | Director |  |
| Alex Huang | Executive Officer, Director |  |
| Chloe Chan | Executive Officer |  |

## Other biotechnology companies in California that filed recently

- [CARI Health, Inc.](https://specstream.ai/data/form-d/company/cari-health-inc-1930994) $280,000 · Nov 6, 2026
- [Ausel, Inc.](https://specstream.ai/data/form-d/company/ausel-inc-2124022) $120,000 · Nov 4, 2026
- [Trellis Bioscience, Inc.](https://specstream.ai/data/form-d/company/trellis-bioscience-inc-1162015) $9.1 million · Oct 29, 2026
- [BigHat Biosciences, Inc.](https://specstream.ai/data/form-d/company/bighat-biosciences-inc-1797256) $75.1 million · Oct 26, 2026
- [Theravie Pharma, Inc.](https://specstream.ai/data/form-d/company/theravie-pharma-inc-2160768) $750,000 · Oct 19, 2026
- [Adela, Inc.](https://specstream.ai/data/form-d/company/adela-inc-1852167) $12 million · Oct 19, 2026

[Every Form D from the week of May 18, 2015](https://specstream.ai/data/form-d/week/2015-05-18) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what LiveLeaf, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).